Takeda's AI‑designed psoriasis pill beats Bristol Myers Squibb's Sotyktu in Phase 3 head‑to‑head trial on June 12, 2026 AI-designed pill Clinical Research Clinical Trials head-to-head psoriasis Psoriasis Area and Severity Index Clinical Classification Sotyktu BIOPHARMA Takeda Takeda FDA filing TYK2 TYK2 inhibitor zasocitinib +